Your search returned 3 results.

Results
	1.	Oncology Care in 2021: the FDA, Medicare, and healthcare reform. [electronic resource] by Gottlieb, Scott Gustafson, Thomas A Johnson, Daniel H Producer: 20110719 In: Oncology (Williston Park, N.Y.) vol. 25 Availability: No items available. Save to lists Add to cart (remove)
	2.	Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity. [electronic resource] by Allen, Tamara Zhang, Fang Moodie, Shonna A Clemens, L Edward Smith, Aaron Gregoire, Francine Bell, Andrea Muscat, George E O Gustafson, Thomas A Producer: 20061024 In: Diabetes vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema. [electronic resource] by Gregoire, Francine M Zhang, Fang Clarke, Holly J Gustafson, Thomas A Sears, Dorothy D Favelyukis, Svetlana Lenhard, James Rentzeperis, Dennis Clemens, L Edward Mu, Yi Lavan, Brian E Producer: 20091012 In: Molecular endocrinology (Baltimore, Md.) vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search